New hope for advanced cancer patients in First-Ever drug trial
Disease control
Recruiting now
This is the first time a new drug called ALK201 is being tested in people. The study aims to find a safe dose and see if it can help shrink tumors in adults with advanced solid cancers that have spread. Researchers will also check how the drug moves through the body and look for …
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Allink Biotherapeutics Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC